Dual role of the coactivator TORC2 in modulating hepatic glucose output and insulin signaling

44Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

Abstract

Under fasting conditions, the cAMP-responsive CREB coactivator TORC2 promotes glucose homeostasis by stimulating the gluconeogenic program in liver. Following its nuclear translocation in response to elevations in circulating glucagon, TORC2 regulates hepatic gene expression via an association with CREB on relevant promoters. Here, we show that, in parallel with their effects on glucose output, CREB and TORC2 also enhance insulin signaling in liver by stimulating expression of the insulin receptor substrate 2 (IRS2) gene. The induction of hepatic IRS2 during fasting appears critical for glucose homeostasis; knockdown of hepatic IRS2 expression leads to glucose intolerance, whereas hepatic IRS2 overexpression attenuates the gluconeogenic program and reduces fasting glucose levels. By stimulating the expression of IRS2 in conjunction with gluconeogenic genes, the CREB:TORC2 pathway thus triggers a feedback response that limits glucose output from the liver during fasting. Copyright © 2005 Elsevier Inc.

Cite

CITATION STYLE

APA

Canettieri, G., Koo, S. H., Berdeaux, R., Heredia, J., Hedrick, S., Zhang, X., & Montminy, M. (2005). Dual role of the coactivator TORC2 in modulating hepatic glucose output and insulin signaling. Cell Metabolism, 2(5), 331–338. https://doi.org/10.1016/j.cmet.2005.09.008

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free